Group structure
8 companies in 4 countries
Loading your page…
Loading your page…
8 companies in 4 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 46
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Aplisol5tu/.1ml · Injection | Tuberculin | United States | Marketed | 1998 |
| AVEED750mg/3ml (250mg/ml) · Injectable | Testosterone | United States | Marketed | 2014 |
| DELATESTRYL200MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Testosterone | United States | Not marketed | 1953 |
| DILATRATE-SR40mg · Capsule, extended release | Isosorbide dinitrate | United States | Not marketed | 1988 |
| EDEX0.005mg/vial | 0.01mg/vial | 0.02mg/vial | 0.04mg/vial · Injectable | Alprostadil | United States | Marketed | 1997 |
| FORTESTA10MG/0.5GM ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Gel, metered | Testosterone | United States | Not marketed | 2010 |
| FROVA2.5mg base · Tablet | Frovatriptan | United States | Not marketed | 2001 |
| LEVATOL10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Penbutolol | United States | Not marketed | 1987 |
| MEGACE ES125mg/ml · Suspension | Megestrol | United States | Not marketed | 2005 |
| MOBAN20mg/ml · Concentrate | Molindone | United States | Not marketed | 1979 |
| NASCOBAL0.5mg/inh · Gel, metered | Vitamin b12 | United States | Not marketed | 1996 |
| NASCOBAL0.5MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Spray, metered | Vitamin b12 | United States | Not marketed | 2005 |
| NUMORPHAN5MG · Suppository | Oxymorphone | United States | Not marketed | 1960 |
| OPANA10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Oxymorphone | United States | Not marketed | 2006 |
| OPANA1.5mg/ml | 1mg/ml · Injectable | Oxymorphone | United States | Not marketed | 1959 |
| OPANA ER10MG | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 15MG | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 30MG · Tablet, extended release | Oxymorphone | United States | Not marketed | 2006 |
| PERCODAN325MG; 4.5MG; 0.38MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 325MG; 4.8355MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Acetylsalicylic acid, Oxycodone | United States | Not marketed | 1950 |
| PERCODAN-DEMI325MG; 2.25MG; 0.19MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Acetylsalicylic acid, Oxycodone, Oxycodone terephthalate | United States | Not marketed | 1950 |
| QWO0.92mg/vial | 1.84mg/vial · Solution | Collagenase clostridium histolyticum | United States | Marketed | 2020 |
| ROBAXIN500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Methocarbamol | United States | Not marketed | 1957 |
| ROBAXIN-750750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Methocarbamol | United States | Not marketed | 1957 |
| SEMPREX-D8MG; 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Acrivastine, Pseudoephedrine | United States | Not marketed | 1994 |
| SUMAVEL DOSEPRO4mg base/0.5ml (eq 8mg base/ml) | 6mg base/0.5ml (eq 12mg base/ml) · Injectable | Sumatriptan | United States | Not marketed | 2009 |
| SUPPRELIN LA50mg · Implant | Histrelin | United States | Marketed | 2007 |
| SYMMETREL50MG/5ML | 50MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Syrup | Amantadine | United States | Not marketed | 1968 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 33 | 33 | 0 | CompaniesAll medicines |
| Canada | 12 | 0 | 12 | CompaniesAll medicines |
| Spain | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of France
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.